Effects of Tryptophan Related Compounds on Nuclear Regulatory Control: Possible Role in the Eosinophilia-Myalgia Syndrome

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 343-350

  Sidransky, H ^a   Verney, E ^a   Latham, P ^a   Schwartz, A ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' ETHYLIDENE BIS(TRYPTOPHAN); 1,1'-ETHYLIDENE BIS(TRYPTOPHAN); 3 (PHENYLAMINO)ALANINE; 3-(PHENYLAMINO)ALANINE; ALANINE; CELL RECEPTOR; DRUG DERIVATIVE; PROTEIN; RNA; TRYPTOPHAN;

ANIMAL; CELL NUCLEUS MEMBRANE; CHEMICALLY INDUCED DISORDER; DRUG CONTAMINATION; DRUG EFFECT; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; LIVER; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ALANINE; ANIMALS; DRUG CONTAMINATION; EOSINOPHILIA-MYALGIA SYNDROME; HUMANS; LIVER; NUCLEAR ENVELOPE; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA; TRYPTOPHAN;

EID: 0030340752     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_53     Document Type: Article

References (47)

1. Back E.E., Henning K.J., Kallenbach L.R., Briz K.A., Gunn R.A., and Melius J.M., 1993, Risk factors for developing eosinophilia-myalgia syndrome among L-tryptophan users in New York. J Rheumatol 20:666.
2. Belongia E.A., Hedberg C.W., Gleich G.J., White K.E., Mayeno A.N., Loegering D.A., Diennetti S.L., Pirie P.L., and MacDonald K.L., and Osterholm M.T., 1990, An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323:357.
3. Belongia E.A., Mayeno A.N., and Osterholm M.T., 1992, The eosinophilia-myalgia syndrome and tryptophan. Annu Rev Nutr 12:235.
4. Buss W.C., Bankhurst A.D., Stephanek J., Pastussn A., and Mayen A.N., 1995, The tryptophan contaminant EBT associated with eosinophilia-myalgia syndrome is an amino acid analog. FASEB J 9:A1028.
5. Cahard D., Canat X., Carayon P., Rogue C., Casella P., and LeFur G., 1994, Subcellular localization of peripheral benzodiazepine receptors on human leukocytes. Lab. Invest 70:23.
6. Cammarano P., Chinali G., Gaetini S., and Spandoni M.A., 1968, Involvement of adrenal steroids in the changes of polysome organization during feeding of imbalanced amino acid diets. Biochem Biophys Acta 155:302.
7. Crofford L.J., Rader J.I., Dalakas M.C., Hall R.H. Jr., Page S.W., Needham L.L., Brody L.S., Heyes M.P., Wilder R.L., and Gold P.W., IlLa I, Smith C, Sternberg E.M., 1990 L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. J Clin Invest 86:1757.
8. Drugan R.C., 1994, Are the nonmitochondrial peripheral benzodiazepine receptors on leukocytes a novel intermediary of brain, behavior and immunity? Lab Invest 70:1
9. Goda Y., Suquki J., Maitani T., Yohihira K., Takeda M., and Uchiuama M., 1992, 3-Anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan sample. Chem Pharm Bull (Tokyo) 40:2236
10. Henning K.J., Jean-Baptiste E., Singh T., Hill R.H., and Friedman S.M., 1993, Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan. J Rheumatol 20:273.
11. Kaufman L.D., Gruber B.L., and Gregerson P.K., 1991, Clinical follow-up on immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Lancet 337:1071.
12. Kurl R.N., Verney E., and Sidransky H., 1987, Tryptophan binding sites on nuclear envelopes of rat liver. Nutr Rep Inter 36:669.
13. Kurl, R.N., Verney E., and Sidransky H., 1988, Identification and immunohistochemical localization of a tryptophan binding protein in nuclear envelopes of rat liver. Arch Biochem Biophys 265:286.
14. Illa I., Dinsmore S., and Dalakas MC., 1993, Immunomedicated mechanisms and immune activation of fibroblasts in the pathogenesis of eosinophilia-myalgia syndrome induced by L-tryptophan. Hum Pathol 24:702.
15. James T.N., Kamb M.L., Sandber G.A., Silver R.M., and Kilbourne E.M., 1991, Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome. Ann Intern Med 115:102.
16. Jorgensen A.J.F., and Majumdar A.P.N., 1975, Bilateral adrenalectomy: Effect of a single tube-feeding of tryptophan on amino acid incorporation into plasma albumin and fibrinogen in vivo. Biochem Med 13:231.
17. Latham P., Verney E., and Sidransky H.. (Unpublished data).
18. Love L.A., Rader J.I., Crofford L.J., and Raybourne R.B., Principato M.A., Page S.W., Trucksess M.W., Smith Dugan M.J., Turner M. L., Zelasonski E., Zelazonski P., and Sternberg E.M., 1993, Pathological and immunological effects of ingesting L-tryptophan and 1,l'-ethylidenebis (tryptophan) in Lewis rats. J Clin Invest 91:804.
19. Majumdar A.P.N., 1982, Tryptophan requirement for protein synthesis. A review. Nutr Rep Int 26:509.
20. Mayeno A.N., Lin F., Foot C.S., Loegering D.A., Ames M.M., Hedberg C.W., and Gleich G.J., 1990, Characterization of "Peak E", a novel amino acid associated with eosinophilia-myalgia syndrome. Science 250:1707.
21. Mayeno A.N., Belongia E.A., Lin F., Lundy S.K., and Gleich G.J., 1992, 3-(phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome. Mayo Clin Proc 67:1134.
22. Oravec M., and Sourkes T.L., 1970, Inhibition of hepatic protein synthesis by a-methyl-DL-tryptophan in vivo.Further studies on the glyconeogenic action of a-methyltryptophan. Biochemistry 9:4458.
23. Park O.J., Henderson M., and Swan P.B., 1973, Effects of the administration of single amino acids on ribosome aggregation in rat liver. Proc Soc Exp Biol Med 142:1023.
24. Pronezuk A.W., Baliga B.S., Triant J.W., and Munro H.S., 1968, Comparison of the effect of amino acid supply on hepatic polysome profiles in vivo and in vitro. Biochem Biophys Acta 157:204.
25. Rocca P., Bellone G., Benna P., Bergamasco B., Ravizza L., and Ferrero P., 1993. Peripheral-type benzodiazepine receptors and diazepam binding inhibitor-like immunoreactivity distribution in human peripheral blood mononuclear cells. Immunopharmacology 25:163.
26. Rothschild M.A., Oratz M., Mongelli J., Fishman L., and Schreiber S.S., 1969, Amino Acid regulation of albumin synthesis. J Nutr 98:395.
27. Sidransky H., 1985, Tryptophan, unique action by an essential amino acid,in: Nutritional Pathology. Pathobiochemistry of Dietary Imbalances. H. Sidransky, ed, Marcel Dekker Inc New York p 1.
28. Sidransky H., 1986, Role of tryptophan in carcinogenesis. In Advances in Experimental Medicine and Biology, Vol 206, Essential Nutrients in Carcinogenesis, edited by L.A. Poirier, P.M. Newberne, N.W. Pariza. p 187, New York, Plenum.
29. Sidransky H., 1994, Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead. Mod Pathol 7:806.
30. Sidransky H., Bongiorno M., Sarma D.S.R., and Verney E., 1967, The influence of tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. Biochem Biophys Res Comm 27:242.
31. Sidransky H., Sarma D.S.R., Bongiorno M., and Verney E., 1968, Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. J Biol Chem 243:1123.
32. Sidransky H., Verney E., and Kurl R.N., 1990, Comparison of effect of L-tryptophan and a tryptophan analog, D,L-a-(l-naphthy)alanine on processes relating to hepatic protein synthesis in rats. J Nutr 120:1157.
33. Sidransky H., Verney E., Cosgrove J.W., Schwartz A.M., 1992a, Studies with compounds that compete with tryptophan binding to rat hepatic nuclei. J Nutr 122:1085.
34. Sidransky H., Verney E., and Cosgrove J.W., 1992b, Competitive studies relating to tryptophan binding to rat hepatic nuclear envelopes as a sensitive assay for unknown compounds. Toxicology 76:89.
35. Sidransky H., Verney E., Cosgrove J.W., and Schwartz A.M., 1992c, Effect of benzodiazepines on tryptophan binding to rat hepatic nuclei. Toxicol Pathol 20:350.
36. Sidransky H., Verney E., Cosgrove J.W., and Schwartz A.M., 1992d, Inhibitory effect of demoxepam of tryptophan binding to rat hepatic nuclei. Biochem Med Metab Biol 47:270.
37. Sidransky H., and Verney E., 1994, Comparative studies on tryptophan binding to hepatic nuclear envelopes in Sprague-Dawley and Lewis rats. Am J Physiol 267:R502.
38. Sidransky H., Verney E., Cosgrove J.W., Latham P. and Schwartz A.M., 1994a, Indolic compounds affect tryptophan binding to rat hepatic nuclei J Nutr 124:779.
39. Sidransky H., Verney E., Cosgrove J.W., Latham P.S., and Mayeno A.N., 1994b, Studies with 1,l'-ethylidenebis (tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome. Toxicol Appl Pharmacol 126:108.
40. Sidransky H., Verney E., Cosgrove J.W., and Latham P.S., 1994c, Effect of 3-phenylamino-L-alanine on tryptophan binding to rat hepatic nuclear envelopes. Toxicology 86:135.
41. Sidransky H., and Verney E., Effect of selenite in rat hepatic nuclei tryptophan receptor. Proc Soc Exp Biol Med (Submitted).
42. Silver R.M., McKinley K., Smith E.A., Quearry B., Harati Y., Sternberg E.M., and Heyes M.P., 1992, Tryptophan metabolism via the kynurenine pathway with the eosinophilia-myalgia syndrome. Arthritis Rhem 35:1097.
43. Slutsker L., Hoesly F.C, Miller L., Williams L.P., Watson J.C., and Fleming D.W., 1990, Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 264:213.
44. Smith M.J., Mazzola E.P., Farrell T.J., Page S.W., Ashley D., Sirimanne S.R., Hill R.H., and Needham L.L., 1991, 1,l'-ethylidenebis(tryptophan) structure determination of contaminant "97" implicated in the eosinophilia-myalgia syndrome (EMS) Tetrahedron Lett 32:991.
45. Varga J., Uitto J., and Jimenez S.A., 1992, The cause and pathogenesis of the eosinophilia-myalgia syndrome.Ann Intern Med 116:140.
46. Varga J., Jimenez S.A., and Uitto J., 1993, L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis. J Invest Dermatol 100:975.
47. Verney E., and Sidransky H., 1994, Effect of metyrapone on tryptophan binding to rat hepatic nuclei. Metabolism 43:79.